🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine the effect of acidic drugs such as proton-pump in...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00426452
Treatments Being Tested
Anti-angiogenesis Tyrosine kinase inhibitors (TKIs) have been proved to sho...
Status
Completed
Location
Musculoskeletal Tumor Center of Peking University People's Hospital
Start Date
2015-06-01
Trial ID
NCT03491371
Treatments Being Tested
The purpose of this study is to determine the effectiveness and safety of A...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01-04
Trial ID
NCT03390062
Treatments Being Tested
The purpose of the study was to characterize the safety of investigational ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-11
Trial ID
NCT01469052
Anlotinib is a novel small molecule multi-target tyrosine kinase inhibitor ...
Status
Unknown
Location
Shandong cancer hospital
Start Date
2019-06-25
Trial ID
NCT04004975
Treatments Being Tested
Objective to compare the efficacy and safety of TQB2450 injection combined ...
Status
Recruiting
Location
The Central People's Hospital of Huizhou
Start Date
2023-04-12
Trial ID
NCT06141226
Treatments Being Tested
The study consists of two parts: Drug Interaction (Pharmacokinetic) Phase a...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2010-09
Trial ID
NCT01149434
Treatments Being Tested
There is no standard treatment strategy for recurrent or metastatic esophag...
Status
Completed
Location
Shanghai Yangpu District East Hospital
Start Date
2017-07-01
Trial ID
NCT03274011
Treatments Being Tested
This open-label, multi-center study will evaluate the safety and efficacy o...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01286753
Treatments Being Tested